SCHEMBL13679674

SCHEMBL13679674

CCCCNc1ccc(C(O)C(O)c2ccc(I)cc2)cc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ LMNA P02545 4/20 0.39
▸ SCN5A Q14524 3/20 0.39
▸ CYP1A2 P05177 2/20 0.39
▸ HRH2 P25021 2/20 0.39
▸ MAPK1 P28482 2/20 0.39
▸ HRH1 P35367 2/20 0.39
▸ DRD3 P35462 2/20 0.39
▸ HTR2B P41595 2/20 0.39
▸ SLC6A3 Q01959 2/20 0.39
▸ KCNH2 Q12809 2/20 0.39
▸ SIGMAR1 Q99720 2/20 0.39
▸ HRH3 Q9Y5N1 2/20 0.39
▸ MAOA P21397 1/20 0.39
▸ CNR1 P21554 1/20 0.39
▸ DRD4 P21917 1/20 0.39
▸ ACHE P22303 1/20 0.39
▸ HTR2A P28223 1/20 0.39
▸ HTR2C P28335 1/20 0.39
▸ NTSR1 P30989 1/20 0.39
▸ SCN1A P35498 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14058913 0.86 MAPT (0.43) LMNASCN5ACYP1A2HRH2MAPK1
SCHEMBL22082127 0.79 ABL1 (0.51) ALDH1A1ABL1
SCHEMBL28802324 0.79 ABL1 (0.51) ALDH1A1ABL1
SCHEMBL27861311 0.79 ABL1 (0.51) ALDH1A1ABL1
SCHEMBL18627182 0.77 LMNA (0.51) LMNASCN5ACYP1A2HRH2MAPK1
SCHEMBL2493444 0.77 LMNA (0.42) LMNASCN5ACYP1A2HRH2MAPK1
SCHEMBL181559 0.76 MAPT (0.52) LMNASCN5ACYP1A2HRH2MAPK1
SCHEMBL854855 0.75 EPHX1 (0.51) LMNASCN5ACYP1A2HRH2MAPK1
SCHEMBL8772822 0.74 MAPT (0.46) ALDH1A1HIF1AGAA
SCHEMBL11476807 0.73 EPHX1 (0.50) LMNASCN5ACYP1A2HRH2MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0999835-B1 IMIDAZOLE DERIVATIVES AS MDR MODULATORS TAIJI BIOMEDICAL INC (US) 2009-09-09 — — EP disclosed
EP-2082740-A2 Use of imidazole derivatives as MDR modulators Taiji Biomedical, Inc. (US) 2009-07-29 — — EP disclosed
Send feedback